Rearrangement of N,N-Di-tert-butoxycarbonylpyridin-4-amines and Formation of Polyfunctional Pyridines
摘要:
N,N-Di-tert-butoxycarbonylpyridin-4-amines were found to be rearranged to tert-butyl 4-(tert-butoxycarbonylamino)nicotinates by treatment with LDA in THF.
[EN] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION<br/>[FR] INHIBITEURS DE LA RÉPLICATION DU VIRUS DE L'IMMUNODÉFICIENCE HUMAINE
申请人:BRISTOL MYERS SQUIBB CO
公开号:WO2016172424A1
公开(公告)日:2016-10-27
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)
The invention relates to a process for preparing aminoarylalkyl compounds, more particularly 5-amino-2-isopropylpyridine.
这项发明涉及一种制备氨基芳基烷基化合物的方法,更具体地说是5-氨基-2-异丙基吡啶的方法。
Verfahren zur Herstellung von Aminoarylalkylverbindungen
申请人:Saltigo GmbH
公开号:EP2415762A2
公开(公告)日:2012-02-08
Die Erfindung betrifft ein Verfahren zur Herstellung von Aminoarylalkylverbindungen, insbesondere des 5-Amino-2-isopropylpyridin.
本发明涉及一种制备氨基芳烷基化合物,特别是 5-氨基-2-异丙基吡啶的工艺。
Inhibitors of human immunodeficiency virus replication
申请人:ViiV HEALTHCARE UK (NO.5) LIMITED
公开号:US10221129B2
公开(公告)日:2019-03-05
Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:
阐述了式 I 的化合物,包括其药学上可接受的盐,以及治疗人类免疫缺陷病毒(HIV)感染的组合物和方法:
INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION